We transform good ideas into great companies through world-class talent.smart capital.global resources.

See how
arrow

We help start-ups break down barriers and move at full speed.

Our proven management team has extensive expertise in the cardiovascular space with robust device development experience. We have strong relationships with global manufacturing partners, a track record of operational excellence, and access to over 3,000 cardiovascular centers in all major geographies.

Our people
arrow

We’re a team of serial medtech entrepreneurs and operators with a proven track record of success.

Our experience
arrow

Over the past two decades, we’ve led projects for a wonderful list of large and small medtech companies.

Check out our companies
arrow
Our partners have incubated some game-changing companies.

Incubated by partners of Big Sky Biomedical, FastWave Medical closed on an equity plus milestone-based acquisition agreement within 6 months of forming the company, which ranks as one of the fastest deals in the history of medtech.

Our first portfolio company, Crossfire Medical is focused on the $1B+ chronic venous insufficiency market and is developing innovative non-tumescent, non-thermal devices as well as cost-effective endovenous radiofrequency ablation catheters.

Our team is actively working on several stealth projects in the interventional arena. If you’re interested in partnering with a group of entrepreneurs that are biased towards execution, stack the odds in your favor and reach out below.

See the buzz
arrow
We’re just getting started, but people are already talking.
FastWave Medical Closes Series Pre-A Financing and Milestone-Based Acquisition Agreement
FastWave Medical Inc., a company incubated by partners of Big Sky Biomedical, announced today the closing of its Series Pre-A financing, led by a strategic partner from Asia. FastWave Medical is focused on providing endovascular solutions for arterial disease.
Read more
arrow
FastWave Medical, a Company Incubated by Partners of Big Sky Biomedical, Closes Series Pre-A Financing and Milestone-based Acquisition
Minority investment will be used to accelerate development and global expansion of the company’s novel endovascular therapies for arterial disease, and includes acquisition obligations upon the completion of key technical, clinical, and regulatory milestones.
Read more
arrow
FastWave Medical, a Company Incubated by Partners of Big Sky Biomedical, Closes Series Pre-A Financing and Milestone-based Acquisition
FastWave Medical Inc., a company incubated by partners of Big Sky Biomedical, announced today the closing of its Series Pre-A financing, led by a strategic partner from Asia. The minority investment will be used to advance research & development and achieve key regulatory initiatives for the company’s novel endovascular therapies for the treatment of calcific artery disease.
Read more
arrow
FastWave Medical closes Series Pre-A funding round, acquired by China Grand Pharmaceutical
Minneapolis-based FastWave Medical, incubated by Big Sky Biomedical partners, earmarked the funds to advance research and development and to achieve key regulatory initiatives for its endovascular therapies to treat calcific artery disease.
Read more
arrow
Get in touch
arrow
Reach out if you’d like to chat.
© Big Sky Biomedical LLC
Back to top
arrow